Neuropsychological correlates of P50 sensory gating in patients with schizophrenia

被引:37
作者
Maria Sanchez-Morla, Eva [1 ,2 ,5 ]
Luis Santos, Jose [1 ]
Aparicio, Ana [1 ]
Angeles Garcia-Jimenez, Mara [3 ]
Soria, Carmen [3 ]
Arango, Celso [4 ]
机构
[1] Hosp Virgen de La Luz, Dept Psychiat, Cuenca, Spain
[2] Hosp Univ Guadalajara, Dept Psychiat, Guadalajara 19002, Spain
[3] Hosp Virgen de La Luz, Neurophysiol Unit, Cuenca, Spain
[4] Hosp Gen Univ GregorioMaranon, Ctr Invest Biomed Red Salud Mental, Child & Adolescent Dept Psychiat, IsSGM,CIBERSAM, Madrid, Spain
[5] Univ Alcala de Henares, Sch Med, Madrid, Spain
关键词
P50; Schizophrenia; Cognition; Evoked potential recordings; Neuropsychological measures; NEUROPHYSIOLOGICAL ENDOPHENOTYPES; DEFICIT; ABNORMALITIES; DYSFUNCTION; CLOZAPINE; BIPOLAR; N100; ANTIPSYCHOTICS; METAANALYSIS; RELIABILITY;
D O I
10.1016/j.schres.2012.10.017
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Impaired inhibition of P50 cerebral evoked response is one of the best validated endophenotypes in schizophrenia. There are controversial data on the relationship between P50 evoked potential deficit and measures of cognitive function in schizophrenia. A comprehensive clinical and neurocognitive assessment plus an evaluation of P50 sensory gating was performed in 160 schizophrenia patients and 64 controls. Neurocognitive scores from each cognitive domain were converted to demographically-adjusted T-scores (age, gender, and years of education) for all study participants. The relationship between P50 and neurocognitive variables was assessed via parametric and nonparametric correlations and categorical strategies: we compared neuropsychological test scores in patients and controls in the lowest P50 quartile vs. the highest. Controls had better performance than schizophrenia patients in all cognitive domains. Schizophrenia patients had significantly higher P50 ratios than controls, and no significant correlation was found between P50 gating measures and neuropsychological test scores in schizophrenia patients or healthy controls. Moreover, no differences in neurocognitive performance were found between subjects in the lowest P50 ratio quartile vs. the highest in healthy controls or patients with schizophrenia. We concluded that there is no evidence of an association between P50 ratio and cognitive measures in schizophrenia patients, and this seems to be also the case in healthy controls. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 55 条
[1]  
ADLER LE, 1982, BIOL PSYCHIAT, V17, P639
[2]   Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients [J].
Adler, LE ;
Olincy, A ;
Cawthra, EM ;
McRae, KA ;
Harris, JG ;
Nagamoto, HT ;
Waldo, MC ;
Hall, MH ;
Bowles, A ;
Woodward, L ;
Randal, R ;
Freedman, R .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (10) :1822-1828
[3]   LACK OF RELATIONSHIP OF AUDITORY GATING DEFECTS TO NEGATIVE SYMPTOMS IN SCHIZOPHRENIA [J].
ADLER, LE ;
WALDO, MC ;
TATCHER, A ;
CAWTHRA, E ;
BAKER, N ;
FREEDMAN, R .
SCHIZOPHRENIA RESEARCH, 1990, 3 (02) :131-138
[4]   Olanzapine effects on auditory sensory gating in schizophrenia [J].
Arango, C ;
Summerfelt, A ;
Buchanan, RW .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (11) :2066-2068
[5]   Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia [J].
Becker, J ;
Gomes, I ;
Ghisolfi, ES ;
Schuch, A ;
Ramos, FLP ;
Ehlers, JA ;
Nora, DB ;
Lara, DR ;
da Costa, JC .
CLINICAL NEUROPHYSIOLOGY, 2004, 115 (02) :396-401
[6]   Regional Differences in the Action of Antipsychotic Drugs: Implications for Cognitive Effects in Schizophrenic Patients [J].
Beninger, Richard J. ;
Baker, Tyson W. ;
Florczynski, Matthew M. ;
Banasikowski, Tomek J. .
NEUROTOXICITY RESEARCH, 2010, 18 (3-4) :229-243
[7]   Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients [J].
Boutros, Nash N. ;
Brockhaus-Dumke, Anke ;
Gjini, Klevest ;
Vedeniapin, Andrei ;
Elfakhani, Mohamad ;
Burroughs, Scott ;
Keshavan, Matcheri .
SCHIZOPHRENIA RESEARCH, 2009, 113 (2-3) :339-346
[8]   Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients [J].
Boutros, NN ;
Korzyukov, O ;
Jansen, B ;
Feingold, A ;
Bell, M .
PSYCHIATRY RESEARCH, 2004, 126 (03) :203-215
[9]   Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature [J].
Bozikas, Vasilis P. ;
Andreou, Christina .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 (02) :93-108
[10]  
BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181